This inventor holds 36 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Drug Delivery Systems. Top assignees: Biocompatibles Limited, Biocompatibles UK Limited, Abbott Laboratories Corporation. Active years: 1997-2018.
Location History:
- Middlesex, GB (1997 - 2002)
- Uxbridge, GB (1997 - 2002)
- Farnham, GB (2000 - 2016)
- Surrey, GB (2000 - 2018)
Company Filing History:
17 out of 43 
12 out of 90 
5 out of 4,186 
Years Active: 1997-2018
Areas of Expertise:
Title: The Innovative Mind of Peter William Stratford: A Profile on His Contributions to Medical Technology
Introduction: Peter William Stratford, based in Surrey, GB, is a notable inventor in the medical technology field, recognized for his significant contributions to innovation with a remarkable portfolio of 36 patents. His work primarily focuses on advanced therapeutic techniques that enhance treatment efficacy for various medical conditions.
Latest Patents: Stratford’s recent innovations include a novel composition for chemoembolotherapy of solid tumors. This invention comprises particles of a water-insoluble, water-swellable synthetic anionic polymer, with the drug doxorubicin being absorbed within. The polymer used is specifically a poly(vinyl alcohol)-based polymer. Another significant patent involves amphiphilic block copolymers designed for nucleic acid delivery. This composition includes vesicles that encapsulate nucleic acids with fewer than 1000 nucleotides, employing an amphiphilic block copolymer structure to facilitate the transport of materials, particularly RNA interference (iRNA) into cells.
Career Highlights: Throughout his career, Peter has contributed to the growth and development of medical technologies at companies such as Biocompatibles Limited and Biocompatibles UK Limited. His work has played a crucial role in evolving treatments that leverage polymer-based drug delivery systems, demonstrating a blend of scientific insight and practical application.
Collaborations: Peter has collaborated with esteemed colleagues, including Stephen A Jones and Andrew Lennard Lewis. These collaborations have fostered significant advancements in their shared field, enriching their combined expertise and driving innovative solutions.
Conclusion: Peter William Stratford's dedication to innovation in medical technology has led to numerous patents and a profound impact on therapeutic techniques. His latest inventions showcase the potential for polymers in drug delivery and cancer treatment, solidifying his reputation as a pioneer in his field.